Disclaimer: this software uses AI to aggregate and filter content. Please double-check sources before putting info to action.
π° News Media
- π [National] Undermining recovery new samhsa requirements threaten opioid use disorder treatment and - healthaffairs.org
- π§‘ [Boston, MA] Inside the lifeline for trafficked women at Mass. and Cass - bostonglobe.com
- β οΈ [upstate New York, NY] Four NY kids killed in grandma, momβs murder-suicide were poisoned with allergy meds, kratom: report - nypost.com
- π [Pontiac, MI] Oakland sheriff's crisis unit gets lifeline after facing uncertainty - detroitnews.com
- π [Baltimore, Maryland] Older Black adults face disproportionate overdose risk despite statewide decline - afro.com
π£οΈ Social Pulse
Lived/Living Experience
Innovation
- π€ Opioid overdose detection and reversal with closed-loop systems - @natrevbioeng on X
- π If you use drugs and want to help with harm reduction, but donβt know where to start, write trip reports. Your experience is valuable data, and these reports can help people. - @aanu_wtf on X
Opposition Views
π Academic Research
- π Novel pharmacotherapies for opioid use disorder and opioid withdrawal - Frontiers in Psychiatry - 2026-09-03 - doi.org
- πΏ βCannabis Green Waveβ versus βNicotine Freezeβ: the regulatory paradox of cannabis liberalization and nicotine prohibition - Harm Reduction Journal - 2026-09-07 - doi.org
- π¨ Evaluating analytically confirmed detections of illicit drugs and novel psychoactive substances in the emergency department and how the findings could contribute to the development of an early warning system. - UWA Profiles and Research Repository (UWA) - 2026-09-03 - doi.org
βοΈ Law & Policy
- No hits in Law and Policy today.
πΈ Funding
Current
- Deadline Approachingπ Bureau of Justice Assistance - BJA FY 2026 Comprehensive Opioid, Stimulant, and Substance Use Site-Based Program - Deadline: Sep 24, 2026
- π¬ National Institutes of Health - Establishing a Center for the Advancement of Substance Use Disorder (SUD) Pharmacotherapeutics through Training and Preclinical Support (U54 Clinical Trial Not Allowed) - Deadline: Sep 30, 2026
- π¬ National Institutes of Health - Limited Competition: Growing Great Ideas: Research Education Course in Entrepreneurship and Product Development for Researchers Studying Drug Use, Drug Misuse, and Drug Addiction (UE5 Clinical Trial Not Allowed) - Deadline: Oct 1, 2026
- π§ Elevance Health Foundation - Deadline: Jan 31, 2027
- π¬ National Institutes of Health - Exploratory Clinical Neuroscience Research on Substance Use Disorders (R61/R33 Clinical Trial Optional) - Deadline: Jun 16, 2028
- π¬ National Institutes of Health - Development of Interventions to Prevent and Treat Substance Use Disorders and Overdose (UG3/UH3 - Clinical Trial Optional) - Deadline: Aug 21, 2028
- π¬ National Institutes of Health - Avant Garde/Avenir Awards for Investigators Conducting High Risk/High Reward Research on HIV and Substance Use (or Substance Use Disorders) (DP1 Clinical Trial Optional) - Deadline: Sep 25, 2028
- π¬ National Institutes of Health - HEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional) - Deadline: Feb 9, 2029
- π©Ί Hearst Foundations - Health - Hearst Foundations (Health) β Year-Round Rolling Grants (FAQ) - Minimum grant size is $100,000. - Deadline: Year-round, rolling application; there are no deadlines.
- π€ Hearst Foundations - Social Service - Hearst Foundations Social Service β Year-Round Grants Portal Application (FAQ) - Minimum grant size is $100,000. - Deadline: Year-round, rolling application; there are no deadlines.
- π€ Smart Family Fund - Angel Philanthropy (First-Time Grants) - First-time grants ranging from $25,000 to $100,000. - Deadline: Open pitch